Intec Pharma Ltd.
Quick facts
Phase 3 pipeline
- Accordion Pill™ Carbidopa/Levodopa · Neurology
The Accordion Pill™ is a modified-release formulation that delivers carbidopa and levodopa sequentially to optimize absorption and reduce motor fluctuations in Parkinson's disease. - Placebo -AP-CD/LD
AP-CD/LD is a placebo formulation designed to serve as a control comparator in clinical trials, containing no active pharmaceutical ingredient. - Placebo- Sinemet · Neurology
Sinemet is a combination of carbidopa and levodopa, which work together to increase dopamine levels in the brain.
Phase 2 pipeline
- AP09004 · Neurology
AP09004 is a drug that targets the dopamine receptor D2. - IN 10 003 formulation A
- IN 10 003 formulation B
- Zaleplon AP formulation
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: